国药一致：2025年第一季度净利润3.28亿元，同比下降15.63%

Group 1 - The core point of the article is that China National Pharmaceutical Group Corporation (国药一致) reported a decline in both revenue and net profit for the first quarter of 2025, indicating potential challenges in its financial performance [1] Group 2 - The company's revenue for the first quarter of 2025 was 18.294 billion yuan, representing a year-on-year decrease of 4.17% [1] - The net profit for the same period was 328 million yuan, which reflects a year-on-year decline of 15.63% [1]